Drug Specific Reviews

Homepage

Search the NeLM

Medicines A-Z

Find key information about medicines by name (prototype)

Browse by Categories:

Browse by NeLM area:

Evidence > Drug Specific Reviews

Medication Safety
Complementary Medicine
Medicines Q & A
Drug Monitoring
(Reviews for Individual Funding Requests (IFRs))

2631 library items in Drug Specific Reviews

Summaries of high quality independent reviews which focus on the safety and efficacy of a particular medicine.

Filter results by:

Date Published

Category

Results filtered by:

Area

Drug Specific Reviews (remove)

Sort by: Display summary:

Results 1 - 10 of 2631

Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next

1.

London Cancer New Drugs Group Rapid Review: Cabazitaxel for the second-line treatment of hormone-refractory metastatic prostate cancer

Source: London Cancer New Drugs Group,
Date published: 09/02/2012

Category:

8.1.5 Other antineoplastic drugs | Cancer: prostate | Drug reviews

NeLM Area:

Evidence > Drug Specific Reviews

Cabazitaxel review
2.

London Cancer New Drugs Group Rapid Review: Everolimus for advanced pancreatic neuroendocrine tumours (pNET)

Source: London Cancer New Drugs Group,
Date published: 09/02/2012

Category:

8.1.5 Other antineoplastic drugs | Cancer: other | Drug reviews

NeLM Area:

Evidence > Drug Specific Reviews

Everolimus_pNET_review
3.

London Cancer New Drugs Group Rapid Review: Erlotinib for the third or fourth-line treatment of NSCLC

Source: London Cancer New Drugs Group,
Date published: 09/02/2012

Category:

8.1.5 Other antineoplastic drugs | Cancer: lung | Drug reviews

NeLM Area:

Evidence > Drug Specific Reviews

Erlotinib_3rd_and_4th_line_reveiw
4.

London Cancer New Drugs Group Rapid Review:Erlotinib for the first-line treatment of advanced NSCLC with EGFR mutation

Source: London Cancer New Drugs Group,
Date published: 08/02/2012

Category:

8.1.5 Other antineoplastic drugs | Cancer: lung

NeLM Area:

Evidence > Drug Specific Reviews

Erlotinib
5.

London Cancer New Drugs Group Rapid Review: SIRT WITH YTTRIUM-90 MICROSPHERES FOR THE THIRD LINE TREATMENT OF LIVER METASTASES FROM COLORECTAL CANCER

Source: London Cancer New Drugs Group,
Date published: 07/02/2012

Category:

Cancer: gastroenterological | Drug reviews

NeLM Area:

Evidence > Drug Specific Reviews

Yttrium_review
6.

London Cancer New Drugs Group Rapid Review: Lapatinib with capecitabine following disease progression on trastuzumab for metastatic breast cancer

Source: London Cancer New Drugs Group,
Date published: 07/02/2012

Category:

8.1 Cytotoxic drugs | 8.1.5 Other antineoplastic drugs | Cancer: breast | Drug reviews

NeLM Area:

Evidence > Drug Specific Reviews

Lapatinib_review
7.

London Cancer New Drugs Group Rapid Review: Folfirinox for first line treatment of advanced pancreatic cancer

Source: London Cancer New Drugs Group,
Date published: 07/02/2012

Category:

8.1 Cytotoxic drugs | 8.1.3 Antimetabolites | 8.1.5 Other antineoplastic drugs | Cancer: pancreas | Drug reviews

NeLM Area:

Evidence > Drug Specific Reviews

Folfirinox_review
8.

Vigabatrin versus carbamazepine monotherapy for epilepsy

Source: Cochrane Library,
Date published: 05/02/2012

Category:

4.8.1 Control of epilepsy | Drug reviews | Epilepsy

NeLM Area:

Evidence > Drug Specific Reviews

Link to Abstract
9.

Tranexamic acid for upper gastrointestinal bleeding

Source: Cochrane Library,
Date published: 05/02/2012

Category:

2.11 Antifibrinolytic drugs and haemostatics | Drug reviews | Gastroenterology

NeLM Area:

Evidence > Drug Specific Reviews

Link to Abstract
10.

Pentoxifylline for intermittent claudication

Source: Cochrane Library,
Date published: 05/02/2012

Category:

2.6 Nitrates, calcium-channel blockers, and other antianginal drugs | Drug reviews | Rheumatology

NeLM Area:

Evidence > Drug Specific Reviews

Link to Abstract

Results 1 - 10 of 2631

Result page:
Previous
|
1
2
3
4
5
6
7
8
9
10
11
|
Next